about
Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia.Aerosolized VEGF in combination with intravenous magnetically targeted delivery of DNA-nanoparticle complex may increase efficiency of cystic fibrosis gene therapy.Conceptual design of integrated microfluidic system for magnetic cell separation, electroporation, and transfection.Probiotic culture genetically modified to produce SDF-1 chemokine may be useful for stem cell based therapy of Crohn's disease.Dynamics of magnetic particles in cylindrical Halbach array: implications for magnetic cell separation and drug targeting.Applications of magnetoliposomes with encapsulated doxorubicin for integrated chemotherapy and hyperthermia of rat C6 glioma.Application of Albumin-embedded Magnetic Nanoheaters for Release of Etoposide in Integrated Chemotherapy and Hyperthermia of U87-MG Glioma Cells.Eigenvalues of Supersymmetric Quantum Matrix ModelsBacteria as a shuttle vector producing SDF-1 for attraction of hematopoietic stem cells to desired sites in bodyNon-invasive method for selective in vivo destruction of nanomachines by resonant absorption of ultrasound energyIn vivoheating of magnetic nanoparticles in alternating magnetic fieldPrinciples of magnetodynamic chemotherapyAC-magnetic field controlled drug release from magnetoliposomes: design of a method for site-specific chemotherapyBlood-specific whole-body electromagnetic hyperthermiaResonant absorption of ultrasound energy as a method of HIV destructionApplication of cationized magnetoferritin for magnetic field-assisted delivery of short interfering RNA in vitro
P50
Q45338034-427717BC-1F29-42CA-A32E-C997FBCBE4D3Q45859294-A94D99DC-02AF-4D17-AAB1-A097D8EA95F4Q45883908-B3920CED-20CE-4C70-95C6-532DE335E1A3Q47729631-CADE3DFD-85C5-453D-A0CB-608D75CF0318Q51693021-C72038F8-51A1-45AE-8D55-4B21614E9A86Q55456852-86134F20-996B-41FD-889D-7065F82A6E2FQ55457218-1A9BF6E4-B83A-449F-A0F9-89EA7CF5B895Q58145452-CD99A54A-5BCF-4151-A780-2477FED13CBFQ58145515-DE008DDA-1BF4-4E66-85B3-3CED5CBDD5E3Q58145529-100FF370-0AA4-480E-8DEF-C5E3FDDAB6E5Q58145568-2D21F396-79F6-40F1-95EA-0BF0A3FDBD04Q58145590-7B08FE5C-AB7A-4873-9325-82B446EF3D7FQ58145608-25C62751-F3B2-4763-A42E-14CFB829B484Q58145662-86365B9F-3F1E-4D76-B95F-75D284815548Q58145687-6BF27C9E-F39A-49A1-90EC-8EA91ECEEAB8Q88917584-BE2D16FF-FC36-442B-A511-CAD51A2BAB95
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter Babinec
@ast
Peter Babinec
@en
Peter Babinec
@es
Peter Babinec
@nl
type
label
Peter Babinec
@ast
Peter Babinec
@en
Peter Babinec
@es
Peter Babinec
@nl
prefLabel
Peter Babinec
@ast
Peter Babinec
@en
Peter Babinec
@es
Peter Babinec
@nl
P1053
T-5186-2018
P106
P1153
7003875736
P31
P3829
P496
0000-0002-4424-3376